newsfilter
← Latest News
GlobeNewswire·

Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split

CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (NASDAQ:ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced